bevantolol has been researched along with Body Weight in 2 studies
bevantolol: structure given in first source
bevantolol : A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical efficacy and safety of bevantolol hydrochloride, a newly developed beta-blocker, used in combination with other types of antihypertensive agents, were evaluated in patients with severe hypertension by multicenter open-label trials." | 9.08 | Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan. ( Arakawa, K; Iimura, O; Inagaki, Y; Ishii, M; Miura, Y; Noshiro, T; Saruta, T; Yamazaki, N; Yoshinaga, K, 1995) |
| "Effects of chronic treatment with bevantolol, a beta-adrenoceptor blocker, and of repeated immobilization stress on blood pressure, body weight, and [3H]dihydroalprenolol ([3H]DHA) binding to the cerebral cortex were examined in rats." | 7.68 | Effects of bevantolol HCl on immobilization stress-induced hypertension and central beta-adrenoceptors in rats. ( Kigoshi, S; Muramatsu, I; Takita, M, 1993) |
| "The clinical efficacy and safety of bevantolol hydrochloride, a newly developed beta-blocker, used in combination with other types of antihypertensive agents, were evaluated in patients with severe hypertension by multicenter open-label trials." | 5.08 | Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan. ( Arakawa, K; Iimura, O; Inagaki, Y; Ishii, M; Miura, Y; Noshiro, T; Saruta, T; Yamazaki, N; Yoshinaga, K, 1995) |
| "Effects of chronic treatment with bevantolol, a beta-adrenoceptor blocker, and of repeated immobilization stress on blood pressure, body weight, and [3H]dihydroalprenolol ([3H]DHA) binding to the cerebral cortex were examined in rats." | 3.68 | Effects of bevantolol HCl on immobilization stress-induced hypertension and central beta-adrenoceptors in rats. ( Kigoshi, S; Muramatsu, I; Takita, M, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noshiro, T | 1 |
| Miura, Y | 1 |
| Yoshinaga, K | 1 |
| Iimura, O | 1 |
| Inagaki, Y | 1 |
| Saruta, T | 1 |
| Ishii, M | 1 |
| Yamazaki, N | 1 |
| Arakawa, K | 1 |
| Takita, M | 1 |
| Kigoshi, S | 1 |
| Muramatsu, I | 1 |
1 trial available for bevantolol and Body Weight
| Article | Year |
|---|---|
Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Chemical Analysis; Blood Pressure; Body Weight; Diur | 1995 |
1 other study available for bevantolol and Body Weight
| Article | Year |
|---|---|
Effects of bevantolol HCl on immobilization stress-induced hypertension and central beta-adrenoceptors in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Cerebral Cortex; Dihydroalprenolo | 1993 |